TrialGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2022

Broad spectrum of regorafenib activity on mutant KIT and absence of clonal selection in gastrointestinal stromal tumor (GIST): correlative analysis from the GRID trial.

Michael Jeffers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.